Assessing the ability of stem cells to develop into retinal cells
Non-destructive assessment of retinal differentiation capacity and developmental maturity
This study is looking to make better stem cell treatments for people with inherited retinal blindness by using a special robot to help create the right kind of cells from each patient, so they can see better in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11040157 on NIH RePORTER |
What this research studies
This research focuses on improving the production of patient-specific stem cell therapies for treating inherited retinal degenerative blindness. By utilizing a robotic cell culture platform, the study aims to enhance the efficiency of generating induced pluripotent stem cells (iPSCs) that can differentiate into retinal cells. The researchers will investigate the variability in differentiation capacity among different patient-derived iPSC lines to optimize therapeutic outcomes. This approach seeks to address the challenges of traditional manufacturing methods that are not tailored for individual patient needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with inherited retinal degenerative conditions who may benefit from stem cell therapies.
Not a fit: Patients with retinal conditions that are not inherited or those who do not have access to stem cell therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for patients suffering from retinal degenerative diseases.
How similar studies have performed: Previous research has shown promise in using stem cell therapies for retinal diseases, indicating that this approach has potential based on earlier successes.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Tucker, Budd a — University of Iowa
- Study coordinator: Tucker, Budd a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.